- Home
- ONC vs IR Comparison
ONC vs IR Comparison
Compare ONC & IR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ONC | IR |
|---|---|---|
| Founded | 2010 | 1859 |
| Country | Switzerland | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Machinery/Components |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 34.8B | 33.9B |
| IPO Year | N/A | 2017 |
Fundamental Metrics
Financial Performance| Metric | ONC | IR |
|---|---|---|
| Price | $317.89 | $93.89 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 12 | 7 |
| Target Price | ★ $377.33 | $99.86 |
| AVG Volume (30 Days) | 234.7K | ★ 4.9M |
| Earning Date | 01-01-0001 | 05-15-2026 |
| Dividend Yield | N/A | ★ 0.09% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 1.45 |
| Revenue | N/A | ★ $2,375,400,000.00 |
| Revenue This Year | $770.07 | $7.11 |
| Revenue Next Year | $15.48 | $4.89 |
| P/E Ratio | $614.06 | ★ $64.65 |
| Revenue Growth | N/A | ★ 22.48 |
| 52 Week Low | $196.53 | $65.61 |
| 52 Week High | $385.22 | $100.96 |
Technical Indicators
Market Signals| Indicator | ONC | IR |
|---|---|---|
| Relative Strength Index (RSI) | 35.71 | 52.42 |
| Support Level | $307.93 | $78.21 |
| Resistance Level | $350.56 | $100.96 |
| Average True Range (ATR) | 10.46 | 2.86 |
| MACD | -4.21 | -0.80 |
| Stochastic Oscillator | 6.49 | 19.13 |
Price Performance
Historical ComparisonAbout ONC BeiGene Ltd. American Depositary Shares
Founded in 2010 in Beijing and having listed on the Hong Kong exchange in 2018, BeOne is a commercial-stage biotechnology company with global sales. It focuses on oncology therapeutics and differentiates itself from other companies with a contract research organization-free, or CRO-free strategy. BeOne runs global clinical trials with its own team. As of 2024, its core drug is Brukinsa, a small molecule drug for various blood cancers that makes up more than 60% of BeOne's revenue.
About IR Ingersoll Rand Inc.
Ingersoll Rand was formed through the merger of Gardner Denver and Ingersoll Rand's industrial segment. The firm's portfolio consists of two business lines: industrial technologies and services, and precision and science technologies. Ingersoll Rand serves a variety of end markets, including industrial, medical, and energy. Its broad portfolio of products includes compression, blower and vacuum, and fluid management. Ingersoll Rand generated roughly $7.2 billion in revenue in 2024.